Clinical trials - Press Releases

Date	Title	Company
29-Jan-2022	Registration is open for SMi’s 22nd Annual Pain Therapeutics Conference	SMi Group
28-Jan-2022	3D Cell Culture Conference takes place in less than 2 weeks as a virtual conference	SMi Group
28-Jan-2022	IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Technology	IAVI and Moderna
28-Jan-2022	4D pharma announces additional positive data from Part A of the Phase I/II trial of MRx-4DP0004 for the treatment of asthma	4D pharma
26-Jan-2022	XBiotech Announces First Patient Enrolled in Phase I Clinical Trial for Novel Arthritis Therapy Natrunix-SQ	XBiotech
26-Jan-2022	Medidata Expands and Strengthens Decentralized Clinical Trial (DCT) Capabilities through Ground breaking Partnership with Circuit Clinical	Medidata
26-Jan-2022	Significantly reduced tumor growth with Tumorad® according to new preclinical results	Spago Nanomedical AB
26-Jan-2022	First patient dosed in randomised Phase 2 clinical trial of MTL-CEBPA in patients with advanced liver cancer	MiNA Therapeutics Limited
26-Jan-2022	Beckley Psytech announces first cohort of psychotherapists have begun training for treatment resistant depression Phase 2 trials	Beckley Psytech
25-Jan-2022	FDA Grants Evrysdi® Priority Review Based on Results From Treating Pre-Symptomatic Infants with Spinal Muscular Atrophy	PTC Therapeutics
20-Jan-2022	ABIVAX’S PHASE 1/2 CLINICAL STUDY RESULTS OF ABX196 IN LIVER CANCER TO BE PRESENTED ON JAN. 21, AT ASCO GI CANCERS SYMPOSIUM 2022	Abivax SA
20-Jan-2022	HUTCHMED Initiates a Phase I Trial of HMPL-653 in Patients with Advanced Malignant Solid Tumors and TGCT in China	HUTCHMED
20-Jan-2022	The Lancet Neurology reports impact of daridorexant on both nighttime symptoms and daytime functioning in adults with insomnia	Idorsia
19-Jan-2022	Second positive Phase 3 Dupixent® (dupilumab) trial confirms significant improvements for patients with prurigo nodularis	Sanofi
19-Jan-2022	Three Companies Join Forces to Become Centricity Research, North America’s Largest lntegrated Research Site Organization	Centricity Research
18-Jan-2022	New Phesi global analysis shows breast cancer was the most extensively studied disease area in 2021	Phesi
18-Jan-2022	Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022	Avance Clinical
13-Jan-2022	Spago Nanomedicals phase 1 study with SpagoPix shows clear contrast enhancement and is expanded into new indications	Spago Nanomedical AB
13-Jan-2022	Captario Has Been Selected by Alnylam Pharmaceuticals To Optimize Their Portfolio Management Process	Captario AB
12-Jan-2022	OncoHost Announces Interim Results from PROPHETIC Trial, Multicenter Assessment of NSCLC Patient Response to Immunotherapy	OncoHost